Amdocs Limited Stock Current Valuation
| AOS Stock | EUR 79.70 1.54 1.90% |
Valuation analysis of Amdocs Limited helps investors to measure Amdocs' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Amdocs' price fluctuation is very steady at this time. Calculation of the real value of Amdocs Limited is based on 3 months time horizon. Increasing Amdocs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Amdocs stock is determined by what a typical buyer is willing to pay for full or partial control of Amdocs Limited. Since Amdocs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amdocs Stock. However, Amdocs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 79.7 | Real 81.68 | Hype 81.24 | Naive 80.51 |
The real value of Amdocs Stock, also known as its intrinsic value, is the underlying worth of Amdocs Limited Company, which is reflected in its stock price. It is based on Amdocs' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Amdocs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Amdocs Limited helps investors to forecast how Amdocs stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amdocs more accurately as focusing exclusively on Amdocs' fundamentals will not take into account other important factors: Amdocs Limited Company Current Valuation Analysis
Amdocs' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Amdocs Current Valuation | 10.29 B |
Most of Amdocs' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amdocs Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Amdocs Limited has a Current Valuation of 10.29 B. This is 46.72% lower than that of the Technology sector and 90.79% lower than that of the Software - Infrastructure industry. The current valuation for all Germany stocks is 38.09% higher than that of the company.
Amdocs Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amdocs' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amdocs could also be used in its relative valuation, which is a method of valuing Amdocs by comparing valuation metrics of similar companies.Amdocs is rated fifth in current valuation category among its peers.
Amdocs Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0652 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 10.29 B | |||
| Shares Outstanding | 120.59 M | |||
| Shares Owned By Insiders | 0.01 % | |||
| Shares Owned By Institutions | 98.75 % | |||
| Price To Earning | 22.06 X | |||
| Price To Book | 2.98 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 4.58 B | |||
| Gross Profit | 1.62 B | |||
| EBITDA | 899.33 M | |||
| Net Income | 549.5 M | |||
| Cash And Equivalents | 449.7 M | |||
| Cash Per Share | 3.28 X | |||
| Total Debt | 645.12 M | |||
| Debt To Equity | 3.30 % | |||
| Current Ratio | 1.35 X | |||
| Book Value Per Share | 29.42 X | |||
| Cash Flow From Operations | 756.72 M | |||
| Earnings Per Share | 4.18 X | |||
| Price To Earnings To Growth | 1.14 X | |||
| Target Price | 87.75 | |||
| Number Of Employees | 31 K | |||
| Beta | 0.66 | |||
| Market Capitalization | 10.24 B | |||
| Total Asset | 6.39 B | |||
| Z Score | 9.0 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.35 % | |||
| Net Asset | 6.39 B | |||
| Last Dividend Paid | 1.58 |
About Amdocs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amdocs Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Amdocs Stock
Amdocs financial ratios help investors to determine whether Amdocs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amdocs with respect to the benefits of owning Amdocs security.